Merritt J E, Armstrong W P, Benham C D, Hallam T J, Jacob R, Jaxa-Chamiec A, Leigh B K, McCarthy S A, Moores K E, Rink T J
SmithKline Beecham Pharmaceuticals, Frythe, Welwyn, Herts, U.K.
Biochem J. 1990 Oct 15;271(2):515-22. doi: 10.1042/bj2710515.
A novel inhibitor of receptor-mediated calcium entry (RMCE) is described. SK&F 96365 (1-(beta-[3-(4-methoxy-phenyl)propoxy]-4-methoxyphenethyl)-1H- imidazole hydrochloride) is structurally distinct from the known 'calcium antagonists' and shows selectivity in blocking RMCE compared with receptor-mediated internal Ca2+ release. Human platelets, neutrophils and endothelial cells were loaded with the fluorescent Ca2(+)-indicator dyes quin2 or fura-2, in order to measure Ca2+ or Mn2+ entry through RMCE as well as Ca2+ release from internal stores. The IC50 (concn. producing 50% inhibition) for inhibition of RMCE by SK&F 96365 in platelets stimulated with ADP or thrombin was 8.5 microM or 11.7 microM respectively; these concentrations of SK&F 96365 did not affect internal Ca2+ release. Similar effects of SK&F 96365 were observed in suspensions of neutrophils and in single endothelial cells. SK&F 96365 also inhibited agonist-stimulated Mn2+ entry in platelets and neutrophils. The effects of SK&F 96365 were independent of cell type and of agonist, as would be expected for a compound that modulates post-receptor events. Voltage-gated Ca2+ entry in fura-2-loaded GH3 (pituitary) cells and rabbit ear-artery smooth-muscle cells held under voltage-clamp was also inhibited by SK&F 96365; however, the ATP-gated Ca2(+)-permeable channel of rabbit ear-artery smooth-muscle cells was unaffected by SK&F 96365. Thus SK&F 96365 (unlike the 'organic Ca2+ antagonists') shows no selectivity between voltage-gated Ca2+ entry and RMCE, although the lack of effect on ATP-gated channels indicates that it discriminates between different types of RMCE. The effects of SK&F 96365 on functional responses of cells thought to be dependent on Ca2+ entry via RMCE were also studied. Under conditions where platelet aggregation is dependent on stimulated Ca2+ entry via RMCE, the response was blocked by SK&F 96365 with an IC50 of 15.9 microM, which is similar to the IC50 of 8-12 microM observed for inhibition of RMCE. Adhesion and chemotaxis of neutrophils were also inhibited by SK&F 96365. SK&F 96365 is a useful tool to distinguish RMCE from internal Ca2+ release, and to probe the role of RMCE in mediating functional responses of cells. However, SK&F 96365 is not as potent (IC50 around 10 microM) or selective (also inhibits voltage-gated Ca2+ entry) as would be desirable, so caution must be exercised when using this compound.
本文描述了一种新型的受体介导的钙内流(RMCE)抑制剂。SK&F 96365(1-(β-[3-(4-甲氧基苯基)丙氧基]-4-甲氧基苯乙基)-1H-咪唑盐酸盐)在结构上与已知的“钙拮抗剂”不同,并且与受体介导的细胞内Ca2+释放相比,在阻断RMCE方面具有选择性。将人血小板、中性粒细胞和内皮细胞用荧光Ca2+指示剂染料喹啉2或fura-2进行负载,以测量通过RMCE的Ca2+或Mn2+内流以及细胞内储存库的Ca2+释放。在由ADP或凝血酶刺激的血小板中,SK&F 96365抑制RMCE的IC50(产生50%抑制的浓度)分别为8.5 microM或11.7 microM;这些浓度的SK&F 96365不影响细胞内Ca2+释放。在中性粒细胞悬液和单个内皮细胞中观察到了SK&F 96365的类似作用。SK&F 96365还抑制激动剂刺激的血小板和中性粒细胞中的Mn2+内流。正如预期的那样,对于调节受体后事件的化合物,SK&F 96365的作用与细胞类型和激动剂无关。在电压钳制下,负载fura-2的GH3(垂体)细胞和兔耳动脉平滑肌细胞中的电压门控Ca2+内流也受到SK&F 96365的抑制;然而,兔耳动脉平滑肌细胞的ATP门控Ca2+渗透通道不受SK&F 96365的影响。因此,SK&F 96365(与“有机Ca2+拮抗剂”不同)在电压门控Ca2+内流和RMCE之间没有显示出选择性;尽管对ATP门控通道没有影响表明它能区分不同类型的RMCE。还研究了SK&F 96365对被认为依赖于通过RMCE的Ca2+内流的细胞功能反应的影响。在血小板聚集依赖于通过RMCE的刺激Ca2+内流的条件下,该反应被SK&F 96365阻断,IC50为15.9 microM,这与观察到的抑制RMCE的IC50为8 - 12 microM相似。中性粒细胞的黏附和趋化性也受到SK&F 96365的抑制。SK&F 96365是区分RMCE和细胞内Ca2+释放以及探究RMCE在介导细胞功能反应中作用的有用工具。然而,SK&F 96365并不像所期望的那样有效(IC50约为10 microM)或具有选择性(也抑制电压门控Ca2+内流),因此在使用该化合物时必须谨慎。